SCHEMBL6523005

SCHEMBL6523005

O=c1[nH]c2nccc(Cl)c2c2ccc(OCCN3CCOCC3)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.53
KDM4E B2RXH2 2/20 0.53
ALDH1A1 P00352 1/20 0.53
PARP1 P09874 1/20 0.52
NPC1 O15118 1/20 0.50
SIGMAR1 Q99720 3/20 0.48
AURKA O14965 1/20 0.47
AURKB Q96GD4 1/20 0.47
ACHE P22303 2/20 0.46
JAK2 O60674 1/20 0.46
PDGFRB P09619 1/20 0.45
FGFR1 P11362 1/20 0.45
KDR P35968 1/20 0.45
MAPK8 P45983 3/20 0.45
CAMKK2 Q96RR4 3/20 0.45
CHUK O15111 2/20 0.45
INSR P06213 2/20 0.45
MAPK14 Q16539 2/20 0.45
TP53 P04637 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6521071 0.95 SIGMAR1 (0.54) MAOAKDM4EALDH1A1PARP1NPC1
SCHEMBL6519482 0.82 SRC (0.57) MAOAKDM4EALDH1A1PARP1NPC1
SCHEMBL6519489 0.77 KDM4E (0.41) MAOAKDM4EALDH1A1PARP1SIGMAR1
SCHEMBL14495853 0.77 KDM4E (0.64) MAOAKDM4EALDH1A1NPC1SIGMAR1
SCHEMBL30499279 0.77 KDM4E (0.64) MAOAKDM4EALDH1A1NPC1SIGMAR1
SCHEMBL15260226 0.73 KDM4E (0.66) MAOAKDM4EALDH1A1NPC1FGFR1
SCHEMBL21676466 0.73 PARP1 (0.62) MAOAKDM4EALDH1A1PARP1NPC1
SCHEMBL31240661 0.72 CAMKK2 (0.51) MAOAKDM4EALDH1A1NPC1MAPK8
Hydrochloric Acid SCHEMBL31070034 0.72 MAOA (0.69) MAOAKDM4EALDH1A1PARP1NPC1
SCHEMBL29992512 0.72 MAOA (0.55) MAOAKDM4EALDH1A1PARP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
WO-2009108670-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK SERONO S.A. (CH) 2009-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MAP4K2, MAP3K20, MAP4K1 MAOA 2577/4885KDM4E 1872/4885ALDH1A1 4501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.